Sub-distribution hazard ratios (95% ci) for cardiovascular disease, non-cardiovascular disease and cancer mortality according to coronary artery calcium score category using competing risk analysis
CACS categories . | Sub-distribution hazard ratios (95% CI)a . | ||
---|---|---|---|
CVD mortality . | Non-CVD mortality . | Cancer mortality . | |
Overall | |||
0 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
>0–100 | 3.75 (1.82–7.75) | 1.19 (0.91–1.55) | 1.13 (0.79–1.63) |
101–300 | 16.33 (6.48–41.14) | 1.58 (1.01–2.48) | 1.36 (0.74–2.47) |
>300 | 18.55 (6.12–56.25) | 2.40 (1.53–3.77) | 2.46 (1.36–4.46) |
P for trend | <0.001 | <0.001 | 0.008 |
Age <45 years | |||
0 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
>0–100 | 5.67 (2.33–13.78) | 0.39 (0.14–1.06) | 0.29 (0.04–2.03) |
101–300 | 22.34 (5.72–87.19) | 3.44 (1.08–10.89) | — |
>300 | 74.1 (18.98–289.30) | 5.49 (0.71–42.28) | — |
P for trend | <0.001 | 0.865 | 0.174 |
Age ≥45 years | |||
0 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
>0–100 | 1.51 (0.60–3.84) | 1.34 (0.99–1.81) | 1.19 (0.80–1.77) |
101–300 | 8.57 (3.05–24.06) | 1.47 (0.91–2.35) | 1.34 (0.72–2.49) |
>300 | 6.41 (1.98–20.74) | 2.30 (1.44–3.68) | 2.35 (1.29–4.30) |
P for trend | <0.001 | 0.001 | 0.012 |
CACS categories . | Sub-distribution hazard ratios (95% CI)a . | ||
---|---|---|---|
CVD mortality . | Non-CVD mortality . | Cancer mortality . | |
Overall | |||
0 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
>0–100 | 3.75 (1.82–7.75) | 1.19 (0.91–1.55) | 1.13 (0.79–1.63) |
101–300 | 16.33 (6.48–41.14) | 1.58 (1.01–2.48) | 1.36 (0.74–2.47) |
>300 | 18.55 (6.12–56.25) | 2.40 (1.53–3.77) | 2.46 (1.36–4.46) |
P for trend | <0.001 | <0.001 | 0.008 |
Age <45 years | |||
0 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
>0–100 | 5.67 (2.33–13.78) | 0.39 (0.14–1.06) | 0.29 (0.04–2.03) |
101–300 | 22.34 (5.72–87.19) | 3.44 (1.08–10.89) | — |
>300 | 74.1 (18.98–289.30) | 5.49 (0.71–42.28) | — |
P for trend | <0.001 | 0.865 | 0.174 |
Age ≥45 years | |||
0 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
>0–100 | 1.51 (0.60–3.84) | 1.34 (0.99–1.81) | 1.19 (0.80–1.77) |
101–300 | 8.57 (3.05–24.06) | 1.47 (0.91–2.35) | 1.34 (0.72–2.49) |
>300 | 6.41 (1.98–20.74) | 2.30 (1.44–3.68) | 2.35 (1.29–4.30) |
P for trend | <0.001 | 0.001 | 0.012 |
CI, confidence interval; CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; LDL-C, low-density lipoprotein cholesterol.
Fine and Gray proportional hazard model with age as a time scale was used to estimate sub-distribution hazard ratios and 95% confidence intervals (CIs). The model was adjusted for age (timescale), sex, centre, year of examination, smoking status, alcohol consumption, physical activity, body mass index, education level, history of diabetes, history of hypertension, family history of CVD (only for CVD mortality), family history of cancer, HOMA-IR, lipid-lowering medication, systolic blood pressure, LDL-C, HDL-C, triglycerides, and glucose.
Sub-distribution hazard ratios (95% ci) for cardiovascular disease, non-cardiovascular disease and cancer mortality according to coronary artery calcium score category using competing risk analysis
CACS categories . | Sub-distribution hazard ratios (95% CI)a . | ||
---|---|---|---|
CVD mortality . | Non-CVD mortality . | Cancer mortality . | |
Overall | |||
0 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
>0–100 | 3.75 (1.82–7.75) | 1.19 (0.91–1.55) | 1.13 (0.79–1.63) |
101–300 | 16.33 (6.48–41.14) | 1.58 (1.01–2.48) | 1.36 (0.74–2.47) |
>300 | 18.55 (6.12–56.25) | 2.40 (1.53–3.77) | 2.46 (1.36–4.46) |
P for trend | <0.001 | <0.001 | 0.008 |
Age <45 years | |||
0 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
>0–100 | 5.67 (2.33–13.78) | 0.39 (0.14–1.06) | 0.29 (0.04–2.03) |
101–300 | 22.34 (5.72–87.19) | 3.44 (1.08–10.89) | — |
>300 | 74.1 (18.98–289.30) | 5.49 (0.71–42.28) | — |
P for trend | <0.001 | 0.865 | 0.174 |
Age ≥45 years | |||
0 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
>0–100 | 1.51 (0.60–3.84) | 1.34 (0.99–1.81) | 1.19 (0.80–1.77) |
101–300 | 8.57 (3.05–24.06) | 1.47 (0.91–2.35) | 1.34 (0.72–2.49) |
>300 | 6.41 (1.98–20.74) | 2.30 (1.44–3.68) | 2.35 (1.29–4.30) |
P for trend | <0.001 | 0.001 | 0.012 |
CACS categories . | Sub-distribution hazard ratios (95% CI)a . | ||
---|---|---|---|
CVD mortality . | Non-CVD mortality . | Cancer mortality . | |
Overall | |||
0 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
>0–100 | 3.75 (1.82–7.75) | 1.19 (0.91–1.55) | 1.13 (0.79–1.63) |
101–300 | 16.33 (6.48–41.14) | 1.58 (1.01–2.48) | 1.36 (0.74–2.47) |
>300 | 18.55 (6.12–56.25) | 2.40 (1.53–3.77) | 2.46 (1.36–4.46) |
P for trend | <0.001 | <0.001 | 0.008 |
Age <45 years | |||
0 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
>0–100 | 5.67 (2.33–13.78) | 0.39 (0.14–1.06) | 0.29 (0.04–2.03) |
101–300 | 22.34 (5.72–87.19) | 3.44 (1.08–10.89) | — |
>300 | 74.1 (18.98–289.30) | 5.49 (0.71–42.28) | — |
P for trend | <0.001 | 0.865 | 0.174 |
Age ≥45 years | |||
0 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
>0–100 | 1.51 (0.60–3.84) | 1.34 (0.99–1.81) | 1.19 (0.80–1.77) |
101–300 | 8.57 (3.05–24.06) | 1.47 (0.91–2.35) | 1.34 (0.72–2.49) |
>300 | 6.41 (1.98–20.74) | 2.30 (1.44–3.68) | 2.35 (1.29–4.30) |
P for trend | <0.001 | 0.001 | 0.012 |
CI, confidence interval; CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; LDL-C, low-density lipoprotein cholesterol.
Fine and Gray proportional hazard model with age as a time scale was used to estimate sub-distribution hazard ratios and 95% confidence intervals (CIs). The model was adjusted for age (timescale), sex, centre, year of examination, smoking status, alcohol consumption, physical activity, body mass index, education level, history of diabetes, history of hypertension, family history of CVD (only for CVD mortality), family history of cancer, HOMA-IR, lipid-lowering medication, systolic blood pressure, LDL-C, HDL-C, triglycerides, and glucose.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.